The Poincaré plot emerges as an effective tool for assessing cardiovascular autonomic regulation. It displays nonlinear characteristics of heart rate variability (HRV) from electrocardiographic (ECG) recordings and gives a global view of the long range of ECG signals. In the telemedicine or computer-aided diagnosis system, it would offer significant auxiliary information for diagnosis if the patterns of the Poincaré plots can be automatically classified. Therefore, we developed an automatic classification system to distinguish five geometric patterns of the Poincaré plots from four types of cardiac arrhythmias. The statistics features are designed on measurements and an ensemble classifier of three types of neural networks is proposed. Aiming at the difficulty to set a proper threshold for classifying the multiple categories, the threshold selection strategy is analyzed. 24 h ECG monitoring recordings from 674 patients, which have four types of cardiac arrhythmias, are adopted for recognition. For comparison, Support Vector Machine (SVM) classifiers with linear and Gaussian kernels are also applied. The experiment results demonstrate the effectiveness of the extracted features and the better performance of the designed classifier. Our study can be applied to diagnose the corresponding sinus rhythm and arrhythmia substrates disease automatically in the telemedicine and computer-aided diagnosis system.
Background: Accurate precision approaches have far not been developed for modeling mortality risk in intensive care unit (ICU) patients. Conventional mortality risk prediction methods can hardly extract the information in longitudinal electronic medical records (EHRs) effectively, since they simply aggregate the heterogeneous variables in EHRs, ignoring the complex relationship and interactions between variables and the time dependence in longitudinal records. Recently deep learning approaches have been widely used in modeling longitudinal EHR data. However, most existing deep learning-based risk prediction approaches only use the information of a single disease, neglecting the interactions between multiple diseases and different conditions. Results: In this paper, we address this unmet need by leveraging disease and treatment information in EHRs to develop a mortality risk prediction model based on deep learning (DeepMPM). DeepMPM utilizes a two-level attention mechanism, i.e. visit-level and variable-level attention, to derive the representation of patient risk status from patient’s multiple longitudinal medical records. Benefiting from using EHR of patients with multiple diseases and different conditions, DeepMPM can achieve state-of-the-art performances in mortality risk prediction. Conclusions: Experiment results on MIMIC III database demonstrates that with the disease and treatment information DeepMPM can achieve a good performance in terms of Area Under ROC Curve (0.85). Moreover, DeepMPM can successfully model the complex interactions between diseases to achieve better representation learning of disease and treatment than other deep learning approaches, so as to improve the accuracy of mortality prediction. A case study also shows that DeepMPM offers the potential to provide users with insights into feature correlation in data as well as model behavior for each prediction.
Summary: We have developed an RNA-Seq analysis workflow for single-ended Illumina reads, termed RseqFlow. This workflow includes a set of analytic functions, such as quality control for sequencing data, signal tracks of mapped reads, calculation of expression levels, identification of differentially expressed genes and coding SNPs calling. This workflow is formalized and managed by the Pegasus Workflow Management System, which maps the analysis modules onto available computational resources, automatically executes the steps in the appropriate order and supervises the whole running process. RseqFlow is available as a Virtual Machine with all the necessary software, which eliminates any complex configuration and installation steps. Availability and implementation:http://genomics.isi.edu/rnaseq Contact:wangying@xmu.edu.cn; knowles@med.usc.edu; deelman@isi.edu; tingchen@usc.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Comparing metagenomic samples is crucial for understanding microbial communities. For different groups of microbial communities, such as human gut metagenomic samples from patients with a certain disease and healthy controls, identifying group-specific sequences offers essential information for potential biomarker discovery. A sequence that is present, or rich, in one group, but absent, or scarce, in another group is considered “group-specific” in our study. Our main purpose is to discover group-specific sequence regions between control and case groups as disease-associated markers. We developed a long k-mer (k ≥ 30 bps)-based computational pipeline to detect group-specific sequences at strain resolution free from reference sequences, sequence alignments, and metagenome-wide de novo assembly. We called our method MetaGO: Group-specific oligonucleotide analysis for metagenomic samples. An open-source pipeline on Apache Spark was developed with parallel computing. We applied MetaGO to one simulated and three real metagenomic datasets to evaluate the discriminative capability of identified group-specific markers. In the simulated dataset, 99.11% of group-specific logical 40-mers covered 98.89% disease-specific regions from the disease-associated strain. In addition, 97.90% of group-specific numerical 40-mers covered 99.61 and 96.39% of differentially abundant genome and regions between two groups, respectively. For a large-scale metagenomic liver cirrhosis (LC)-associated dataset, we identified 37,647 group-specific 40-mer features. Any one of the features can predict disease status of the training samples with the average of sensitivity and specificity higher than 0.8. The random forests classification using the top 10 group-specific features yielded a higher AUC (from ∼0.8 to ∼0.9) than that of previous studies. All group-specific 40-mers were present in LC patients, but not healthy controls. All the assembled 11 LC-specific sequences can be mapped to two strains of Veillonella parvula: UTDB1-3 and DSM2008. The experiments on the other two real datasets related to Inflammatory Bowel Disease and Type 2 Diabetes in Women consistently demonstrated that MetaGO achieved better prediction accuracy with fewer features compared to previous studies. The experiments showed that MetaGO is a powerful tool for identifying group-specific k-mers, which would be clinically applicable for disease prediction. MetaGO is available at https://github.com/VVsmileyx/MetaGO.
The comparison between microbial sequencing data is critical to understand the dynamics of microbial communities. The alignment-based tools analyzing metagenomic datasets require reference sequences and read alignments. The available alignment-free dissimilarity approaches model the background sequences with Fixed Order Markov Chain (FOMC) yielding promising results for the comparison of microbial communities. However, in FOMC, the number of parameters grows exponentially with the increase of the order of Markov Chain (MC). Under a fixed high order of MC, the parameters might not be accurately estimated owing to the limitation of sequencing depth. In our study, we investigate an alternative to FOMC to model background sequences with the data-driven Variable Length Markov Chain (VLMC) in metatranscriptomic data. The VLMC originally designed for long sequences was extended to apply to high-throughput sequencing reads and the strategies to estimate the corresponding parameters were developed. The flexible number of parameters in VLMC avoids estimating the vast number of parameters of high-order MC under limited sequencing depth. Different from the manual selection in FOMC, VLMC determines the MC order adaptively. Several beta diversity measures based on VLMC were applied to compare the bacterial RNA-Seq and metatranscriptomic datasets. Experiments show that VLMC outperforms FOMC to model the background sequences in transcriptomic and metatranscriptomic samples. A software pipeline is available at https://d2vlmc.codeplex.com.
Capturing group-specific sequences between two groups of genomic/metagenomic sequences is critical for the follow-up identifications of singular nucleotide variants (SNVs), gene families, microbial species or other elements associated with each group. A sequence that is present, or rich, in one group, but absent, or scarce, in another group is considered a “group-specific” sequence in our study. We developed a user-friendly tool, KmerGO, to identify group-specific sequences between two groups of genomic/metagenomic long sequences or high-throughput sequencing datasets. Compared with other tools, KmerGO captures group-specific k-mers (k up to 40 bps) with much lower requirements for computing resources in much shorter running time. For a 1.05 TB dataset (.fasta), it takes KmerGO about 21.5 h (including k-mer counting) to return assembled group-specific sequences on a regular stand-alone workstation with no more than 1 GB memory. Furthermore, KmerGO can also be applied to capture trait-associated sequences for continuous-trait. Through multi-process parallel computing, KmerGO is implemented with both graphic user interface and command line on Linux and Windows free from any pre-installed supporting environments, packages, and complex configurations. The output group-specific k-mers or sequences from KmerGO could be the inputs of other tools for the downstream discovery of biomarkers, such as genetic variants, species, or genes. KmerGO is available at https://github.com/ChnMasterOG/KmerGO.